Does the Form 4 provide exact prices for each share sold?

No; the filing provides a price range ($16.76 to $17.27) and states the filer will provide the number of shares sold at each price within that range upon request.

CFLT Form 4: CEO/Director Sells 37,707 Shares Under 10b5-1 Plan

Q: What did Confluent (CFLT) insider Edward Jay Kreps report on Form 4?

The Form 4 reports a sale of 37,707 Class A shares on 08/20/2025 executed under a 10b5-1 plan, with sale prices ranging from $16.76 to $17.27 .

Q: Was the sale by the insider preplanned or discretionary?

The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted August 15, 2024 , indicating it was preplanned.

Q: How many shares does the reporting person own after the reported transaction?

The Form 4 reports 377,074 shares of Class A common stock beneficially owned following the transaction.

Q: Who signed the Form 4 and when?

The Form 4 was signed by an attorney-in-fact, /s/ Weilyn Wood , on 08/22/2025 .

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Confluent, Inc. (CFLT) Form 4: The reporting person, Edward Jay Kreps, who is listed as both a director and the Chief Executive Officer, reported the sale of 37,707 shares of Class A common stock on 08/20/2025 under a Rule 10b5-1 trading plan adopted August 15, 2024. The shares were sold at prices ranging from $16.76 to $17.27. After the reported sale, the filing shows 377,074 shares of Class A common stock beneficially owned by the reporting person. The Form 4 was signed by an attorney-in-fact on 08/22/2025. The filer states they will provide details on the number of shares sold at each price in the stated range upon request.

Positive

Sale executed under a 10b5-1 plan, indicating the transaction was pre-scheduled and intended to mitigate appearance of trading on nonpublic information
Filing discloses price range ($16.76 to $17.27) and post-transaction beneficial ownership (377,074 shares), providing clear transparency

Negative

Sale by CEO/director may be interpreted by some market participants as a reduction in insider holdings, though no motive is disclosed
Form does not specify exact allocation of shares sold at each price within the range; additional breakdown is available only upon request

Insights

TL;DR: CEO/director sold 37,707 shares under a pre-established 10b5-1 plan; remaining beneficial ownership shown as 377,074 shares.

The transaction is a routine insider sale executed pursuant to a 10b5-1 plan, which limits contemporaneous trading questions by signaling the sale was pre-planned on August 15, 2024. The disclosed sale price range of $16.76 to $17.27 and the remaining beneficial ownership of 377,074 shares are factual and allow investors to update outstanding insider holdings. The Form 4 provides no information about company performance or motives beyond the existence of the plan; any interpretation beyond these stated facts would be speculative.

TL;DR: Insider sale follows a documented 10b5-1 plan; disclosure is compliant and includes share-range pricing and post-sale holdings.

The filing clearly indicates the sale was made pursuant to a 10b5-1 written plan adopted on August 15, 2024, which is a recognized compliance mechanism for insiders. The disclosure includes the price range and affirms the filer will provide detailed allocation of sales within that range upon request. Signature by an attorney-in-fact is provided, satisfying execution formalities. The form contains no adverse regulatory or governance flags in itself.

Insider Trade Summary

Net Seller: 37,707 shares ($642,527)

Net Sell 1 txn

Insider Kreps Edward Jay

Role CHIEF EXECUTIVE OFFICER

Sold 37,707 shs ($643K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	37,707	$17.04	$643K

Holdings After Transaction: Class A Common Stock — 377,074 shares (Direct)

Footnotes (1)

Shares sold pursuant to a 10b5-1 trading plan adopted August 15, 2024. The shares were sold at prices ranging from $16.76 to $17.27. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Form 4 Insider Transactions: What Each Field Means →

08/22/2025 - 07:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kreps Edward Jay

(Last)

(First)

(Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW

94041

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	08/20/2025		S		37,707⁽¹⁾	D	$17.04⁽²⁾	377,074	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares sold pursuant to a 10b5-1 trading plan adopted August 15, 2024.

2. The shares were sold at prices ranging from $16.76 to $17.27. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Weilyn Wood, Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Confluent (CFLT) insider Edward Jay Kreps report on Form 4?

The Form 4 reports a sale of 37,707 Class A shares on 08/20/2025 executed under a 10b5-1 plan, with sale prices ranging from $16.76 to $17.27.

Was the sale by the insider preplanned or discretionary?

The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted August 15, 2024, indicating it was preplanned.

How many shares does the reporting person own after the reported transaction?

The Form 4 reports 377,074 shares of Class A common stock beneficially owned following the transaction.

Who signed the Form 4 and when?

The Form 4 was signed by an attorney-in-fact, /s/ Weilyn Wood, on 08/22/2025.